{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:11:25Z","timestamp":1760645485793},"reference-count":71,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,7,11]],"date-time":"2007-07-11T00:00:00Z","timestamp":1184112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2003<\/jats:bold> Patients with fractures should be prioritized for assessment for osteoporosis so that they can benefit from treatment for the secondary prevention of osteoporotic fractures. Assessment is seldom offered to patients with vertebral fractures because these fractures are typically not diagnosed. Vertebral fractures can be identified by vertebral fracture assessment (VFA) using current dual\u2010energy X\u2010ray absorptiometry (DXA) scanners.<\/jats:p><jats:p><jats:bold>Objective\u2003<\/jats:bold> The purpose of this study was to assess the prevalence of vertebral fractures, using VFA, in patients presenting with nonvertebral fractures and to assess whether this impacts on the management of these patients.<\/jats:p><jats:p><jats:bold>Design\u2003<\/jats:bold> A cohort study undertaken in 577 patients aged 50\u00a0years or over including 455 women, who presented with nonvertebral fractures and who underwent routine post\u2010fracture assessment by a Fracture Liaison Service (FLS).<\/jats:p><jats:p><jats:bold>Measurements\u2003<\/jats:bold> The numbers and severity of vertebral fractures were assessed in evaluable vertebrae from TV4 to LV4 in addition to bone mineral density (BMD) assessment.<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold> Using DXA, 76% of vertebrae could be evaluated by VFA. Of the men and women with nonvertebral fractures, 19\u201320% had at least one vertebral fracture. The prevalence ranged from 6% in men with humeral fractures to 32% among women with hip fractures. The prevalence of vertebral fractures correlated most strongly with increasing age and with severity of reduction of BMD. Using local treatment protocols, VFA would result in only 3% more patients receiving treatment for fracture secondary prevention.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> In patients with nonvertebral fractures, VFA identifies a substantial burden of prevalent vertebral fractures that have not hitherto been recognized. Nevertheless, VFA seldom influences the need for treatment for fracture secondary prevention after a nonvertebral fracture.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2007.02988.x","type":"journal-article","created":{"date-parts":[[2007,9,7]],"date-time":"2007-09-07T20:22:56Z","timestamp":1189196576000},"page":"923-930","source":"Crossref","is-referenced-by-count":25,"title":["Vertebral fracture assessment in patients presenting with incident nonvertebral fractures"],"prefix":"10.1111","volume":"67","author":[{"given":"Isobel","family":"Howat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Carty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayrine","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair R.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,29]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01626603"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.1.24"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980070075"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6914.1248"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623276"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archinte.1996.00440130053006","article-title":"Mortality following fractures in older women. The study of osteoporotic fractures","volume":"156","author":"Browner W.S.","year":"1996","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050067"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1490-4"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)09075-8"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-11-919"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503233321202"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.4.721"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.3.320"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050107"},{"key":"e_1_2_5_16_2","first-page":"S1","article-title":"2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown J.P.","year":"2002","journal-title":"CMAJ: Canadian Medical Association Journal"},{"key":"e_1_2_5_17_2","first-page":"31","article-title":"Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide","volume":"55","author":"Heinemann D.F.","year":"2000","journal-title":"Geriatrics"},{"key":"e_1_2_5_18_2","first-page":"293","article-title":"American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis","volume":"7","author":"Hodgson S.F.","year":"2001","journal-title":"Endocrine Practice"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/000164701753541952"},{"key":"e_1_2_5_20_2","volume-title":"Clinical Guidelines for the Prevention and Treatment of Osteoporosis","author":"Royal College of Physicians","year":"1999"},{"key":"e_1_2_5_21_2","volume-title":"Clinical Guidelines for the Prevention and Treatment of Osteoporosis","author":"Royal College of Physicians","year":"2000"},{"key":"e_1_2_5_22_2","unstructured":"Scottish Intercollegiate Guidelines Network(2003)Management of Osteoporosis: A National Guideline. SIGN publication no. 71. Available online at:http:\/\/www.sign.ac.uk\/pdf\/sign71.pdf."},{"key":"e_1_2_5_23_2","first-page":"S1","article-title":"The prevention and management of osteoporosis. Consensus statement of the 1996 Australian National Consensus Conference","volume":"167","author":"Department of Health","year":"1997","journal-title":"Medical Journal of Australia"},{"issue":"4","key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1007\/PL00022721","article-title":"Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost\u2010effectiveness analysis","volume":"8","author":"National Osteoporosis Foundation","year":"1998","journal-title":"Osteoporosis International"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01622192"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7041.1254"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07088-2"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.24.2077"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00004171"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.7.637"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102013440503"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050010"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.14.1344"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1774"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040325"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.57.6.378"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030568"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.18.2165"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200208000-00008"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.19.2217"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1543-5946(04)90016-5"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1544-7"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)90025-5"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650070214"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.040901"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.11.1215"},{"key":"e_1_2_5_48_2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s001980070078","article-title":"Recognition of vertebral fracture in a clinical setting","volume":"11","author":"Gehlbach S.H.","year":"2000","journal-title":"Osteoporosis International"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1507-z"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623272"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.5.496"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.3.464"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-2998(97)80029-3"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1385\/JCD:3:3:281"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1385\/JCD:4:4:373"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.3.575"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.5.933"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2005.11.002"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.3.564"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980070063"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1385\/JCD:8:3:362"},{"key":"e_1_2_5_62_2","first-page":"286","article-title":"A fracture liaison service for patients with osteoporotic fractures","volume":"19","author":"Fraser M.","year":"2004","journal-title":"Professional Nurse"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050093"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2005.08.002"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650080915"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650110602"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050138"},{"key":"e_1_2_5_68_2","unstructured":"National Institute for Clinical Excellence(2005)Technology Appraisal 87: Bisphosphonates (alendronate etidronate risedronate) selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women.National Institute for Clinical Excellence London. Available online at:http:\/\/guidance.nice.org.uk\/TA87."},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623271"},{"key":"e_1_2_5_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116756"},{"key":"e_1_2_5_71_2","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.1996.00440120051005","article-title":"Osteoporosis. Frequency, consequences, and risk factors","volume":"156","author":"Ross P.D.","year":"1996","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_5_72_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-10-199805150-00001"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2007.02988.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2007.02988.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T13:05:53Z","timestamp":1697202353000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2007.02988.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,29]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1365-2265.2007.02988.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02988.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,29]]}}}